Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORWARD trial of intra-articular sprifermin in knee osteoarthritis
2011-003059-20Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) and primary osteoarthritis (OA) comparing Sprifermin dose regimen arm(s) with Placebo (2 arms). Primary endpoint: Change from baseline in cartilage thickness in the total femorotibial joint. Started May 2013; status: completed.
02
Drugs
sprifermin
03
Conditions
knee osteoarthritis (OA)primary osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-003059-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003059-20.